|Having trouble viewing this email? Click here|
Physicians: .25 AMA PRA Category I CreditsTM
To Receive Credit
In order to receive your certificate of participation, you should read the information about this activity, including the disclosure statements, review the entire activity, take the post-test, and complete the evaluation form. You may then follow the directions to print your certificate of participation. To begin, click the CME icon above.
Upon successful completion of this educational program, the reader should be able to:
Alan Ehrlich, MD
Dr. Ehrlich, Dr. Fleming, DynaMed Editorial Team members, and the staff of Antidote Education Company have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.
ACCME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Antidote Education Company and EBSCO Publishing. Antidote is accredited by the ACCME to provide continuing medical education for physicians. Antidote Education Company designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Call for Peer Reviews
We are currently seeking subspecialty reviewers for our Patient Education Resource Center (PERC). PERC provides fact sheets and discharge instructions for patients leaving the hospital or emergency room. These hand-outs fulfill the meaningful use requirements for the Medicare & Medicare Services Incentive Programs.
Screening and Treatment of Thyroid Dysfunction
In 2004 the United States Preventive Services Task Force (USPSTF) found insufficient evidence to recommend for or against screening for thyroid disease in asymptomatic adults. Revisiting the evidence 10 years later finds little to update. No study directly assessed benefits and harms of screening. For treatment of subclinical hypothyroidism, 1 fair-quality cohort study found an association with decreased risk for coronary heart disease events, but no study has found benefits for quality of life, cognitive function, blood pressure, or body mass index. No study evaluated clinical outcomes with treatment of subclinical hyperthyroidism. No study evaluated treatment of screen-detected overt thyroid dysfunction compared to no treatment or waiting for symptomatic presentation to initiate treatment.
The optimal timing of aortic valve replacement in patients with severe aortic stenosis is currently unclear, and risk stratification may help identify patients more likely to benefit. Several studies have shown that elevated resting brain natriuretic peptide (BNP) levels are associated with increased risk of poor outcome (Curr Cardiol Rep 2009 Mar;11(2):85, Circulation 2004 May 18;109(19):2302 full-text, Am J Cardiol 2005 Nov 15;96(10):1445, and Circulation 2007 Jun 5;115(22):2848 full-text). A recent study evaluated peak exercise BNP measurement for prediction of aortic valve replacement or death in 157 patients with asymptomatic severe aortic stenosis.
A peak exercise BNP >86 pg/mL was identified as the optimal cutoff for detection of aortic valve replacement or death. When compared to resting BNP, peak exercise BNP using optimal cutoffs was associated with an improved predictive performance of aortic valve replacement or death at 1 year (p < 0.0001).
Recently Released Choosing Wisely Canada Recommendations Added to DynaMed
October 29, 2014: Recommendations from 12 Organizations are Now Easily Accessible at the Point-of-Care
Choosing Wisely Canada just released 61 new recommendations that are now available in DynaMed. These recommendations are intended to help clinicians and patients avoid unnecessary tests and treatments, and are compiled from 12 specialty societies.
The DynaMed editorial team is seeking specialist editors in the following fields: ENT, Gastroenterology, Hematology, Nephrology, Ophthalmology, Orthopedics, Surgery, and Vascular.
PEMSoft Now Available For iPhone, iPad, and Android Devices
The PEMSoft Mobile app, a pediatric evidence-based point-of-care medical reference tool for hospitals, emergency departments, clinics, pediatric group practices, transport services, and medical schools, is now available from EBSCOHealth. Designed by pediatricians, emergency physicians and other medical specialists, the vast content in PEMSoft addresses the entire spectrum of neonatal, infant, child, adolescent and young adult health. PEMSoft authors adhere to a strict evidence-based editorial policy focused on systematic identification, evaluation and consolidation of practice-changing clinical literature.
DynaMed Contribution Opportunities